Concepedia

Decai Yu

DY

Statistics

Publications

60

Citations

2.7K

H-Index

30

Active since

2003

Affiliations

Nanjing Drum Tower Hospital(Current)

Nanjing University

Nanjing Medical University

China Pharmaceutical University

Model Animal Research Center

Decai Yu is an author at Nanjing Drum Tower Hospital specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2003–2024

60

Publications

60

Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway

Binghua Li, Yajuan Cao, Gang Meng et al. · EBioMedicine · 2018 · 240 citations · Full text

, , +17

Cancer‐Cell Targeting and Photoacoustic Therapy Using Carbon Nanotubes as “Bomb” Agents

Bin Kang, Decai Yu, Yaodong Dai et al. · Small · 2009 · 153 citations · Full text

, , +17

Cell Response to Carbon Nanotubes: Size‐Dependent Intracellular Uptake Mechanism and Subcellular Fate

Bin Kang, Shuquan Chang, Yaodong Dai et al. · Small · 2010 · 130 citations · Full text

, , +15

Kidney-type glutaminase (GLS1) is a biomarker for pathologic diagnosis and prognosis of hepatocellular carcinoma

Decai Yu, Gang Meng, Jun Chen et al. · Oncotarget · 2015 · 115 citations · Full text

, , +17

APOBEC3B interaction with PRC2 modulates microenvironment to promote HCC progression

Duowei Wang, Xianjing Li, Jiani Li et al. · Gut · 2019 · 102 citations

, , +17

1–5 of 60